Literature DB >> 10502583

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid.

O Cekiç1, C Batman, U Yasar, Y Totan, N E Basci, A Bozkurt, O Zilelioglu, S O Kayaalp.   

Abstract

AIMS: To assess the subretinal fluid (SRF) levels of ofloxacin following topical, oral or combined administration.
METHODS: 31 patients undergoing conventional retinal reattachment surgery were randomly assigned to three groups. Nine patients received topical ofloxacin, 11 patients received oral ofloxacin, and the other 11 patients received combined administration. Collected SRF samples were analysed for drug level by using high performance liquid chromatography.
RESULTS: SRF drug levels after oral and combined administration were significantly higher than that after topical administration (p=0.0002 and p=0.0002, respectively) while there was no significant difference between oral and combined administration (p=0.0844).
CONCLUSIONS: Ocular bioavailability of ofloxacin in SRF after oral and combined administration is equivalent. The addition of oral ofloxacin to topical therapy increased drug SRF penetration sixfold.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502583      PMCID: PMC1722819          DOI: 10.1136/bjo.83.10.1183

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.

Authors:  W Behrens-Baumann
Journal:  Ophthalmologica       Date:  1996       Impact factor: 3.250

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.

Authors:  E D Donnenfeld; H D Perry; R W Snyder; R Moadel; M Elsky; H Jones
Journal:  Arch Ophthalmol       Date:  1997-02

4.  Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection.

Authors:  N E Basci; S Hanioglu-Kargi; H Soysal; A Bozkurt; S O Kayaalp
Journal:  J Pharm Biomed Anal       Date:  1997-02       Impact factor: 3.935

Review 5.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

6.  Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin.

Authors:  B Durmaz; S Marol; R Durmaz; O Oram; I F Hepsen; S Günal
Journal:  Arzneimittelforschung       Date:  1997-04

7.  Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin.

Authors:  D V Alfaro; J Davis; S Kim; F Bia; J F Bogard; J W Briggs; P E Liggett
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

8.  Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits.

Authors:  G Gatti; G Panozzo
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

9.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.

Authors:  A Gwon
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

10.  Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.

Authors:  J P Diamond; L White; J P Leeming; H Bing Hoh; D L Easty
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

View more
  3 in total

1.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

2.  Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.

Authors:  O Cekiç; C Batman; U Yaşar; N E Başci; O Zilelioğlu; A Bozkurt
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

3.  Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.

Authors:  Seung Yong Choi; Hyun-A Lim; Hyeon Woo Yim; Young-Hoon Park
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.